Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280184 · ClinicalTrials.gov registry record · NA
Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens
A NA study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- NA
- Development phase
- 173
- Enrollment target
NCT05280184 is a NA study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 173 participants.
The verdict
NCT05280184, a NA study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
Study Summary
Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS scores in adolescents with suboptimal insulin use.
Interventions
- BEHAVIORAL Coin2Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05280184
The ClinicalTrials.gov registry entry for NCT05280184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coin2Dose is the first listed.
NCT05280184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05280184 about?
NCT05280184 is a clinical study titled "Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens". Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS scores in adolescents with suboptimal insulin use.
What is the current status of trial NCT05280184?
This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2023-01-01. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05280184?
The interventions under investigation include: Coin2Dose (BEHAVIORAL).
Who is sponsoring clinical trial NCT05280184?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.